MedTrace Logo

Vascular Abnormalities Detected With Chest CT in COVID-19

NCT04824313 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2021-04-01

No results posted yet for this study

Summary

Chest computed tomography of patients having coronavirus disease (COVID-19) will be analyzed with regards to vascular abnormalities (pulmonary embolism and vascular thickening), and their association with lung inflammation. The prevalence, severity, distribution, and prognostic value of chest CT findings will be assessed. Patients with vascular abnormalities will be compared to patients without, which is supposed to provide insights into the prognostic role of such abnormalities, and the potential impact on treatment strategy.

Conditions

Interventions

DIAGNOSTIC_TEST

Chest CT

Chest CT without intravenous contrast material

DIAGNOSTIC_TEST

Chest CTA

Chest CT with intravenous contrast material

Sponsors & Collaborators

  • University of Geneva, Switzerland

    collaborator OTHER

  • University of Bern

    collaborator OTHER

  • University of Basel

    collaborator OTHER

  • University of Zurich

    collaborator OTHER

  • Salah D. Qanadli

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-01
Primary Completion
2020-07-31
Completion
2021-03-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04824313 on ClinicalTrials.gov